NCT05264090

Brief Summary

Specify the risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2020

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 3, 2022

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

2 years

First QC Date

February 9, 2022

Last Update Submit

February 21, 2022

Conditions

Keywords

ambulatory blood pressure monitoringhypertensionnight-to-day ratioexercise

Outcome Measures

Primary Outcomes (1)

  • The risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring.

    Primary outcome was to specify the risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring. The percentage of blood pressure drop at night expressed by night-to-day ratio (dippers, non-dippers, extreme dippers, reverse dippers) can be specified much more accurately on the basis of 7-day ABPM values. ABPM restricted to 24 h, as currently practiced, does not yield a sufficiently reliable estimate of the night-to-day ratio for a classification in terms of dipping. Extending monitoring to 7 days accounts for the large day-to-day variability in the night-to-day ratio, and may yield a more reliable diagnosis of blood pressure variability.

    1 - 7 days

Secondary Outcomes (1)

  • Optimalization of the blood pressure diagnostic through comparing of 24 hours and 7 days monitoring.

    1 - 7 days

Study Arms (4)

Group 1

PLACEBO COMPARATOR

Healthy volunteers without exercise

Other: Ambulatory blood pressure monitoring

Group 2

SHAM COMPARATOR

Healthy exercise-training volunteers

Other: Ambulatory blood pressure monitoringOther: Combined aerobic-resistance exercise

Group 3

ACTIVE COMPARATOR

Patients with ischemic coronary artery disease without exercise

Other: Ambulatory blood pressure monitoring

Group 4

EXPERIMENTAL

Patients with ischemic coronary artery disease following cardiovascular rehabilitation

Other: Ambulatory blood pressure monitoringOther: The cardiovascular exercise

Interventions

The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A\&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method. The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement. The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene. During every automatic measurement, the arm was resting and hung along the body. The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m. every 60 minutes. Such short intervals are necessary to obtain a sufficient number of representative measurements.

Group 1Group 2Group 3Group 4

Combined aerobic-resistance exercise (group 2) was scheduled twice weekly in the form of 60-minute workouts with a load intensity at the level of sub-maximum heart frequency (75-85% SFmax). The minimum time span between the workouts was 24 hours. The workout consisted of a 10-minute warm-up, 25 minutes of aerobic exercise (spinning bicycle or bicycle ergometer), 15 minutes of resistance exercise on gym machines (bench press, leg extension and pull down) with 40-50% 1-RM (one repetition maximum) intensity (3 series of 10 exercises), and a 10-minute cool-down (stretching of the main muscle groups).

Group 2

The cardiovascular exercise (group 4) took the form of sixty-minute workouts scheduled two to three times weekly. The nature of the workouts was similar, combined aerobic-resistance exercise (a 10-minute warm-up, aerobic endurance on bicycle ergo meter for 25 minutes, resistance exercise on multifunctional gym machines for 15 minutes, and a 10-minute cool-down). The workout intensity was set at the level of the first ventilation threshold (VAT-1), corresponding to the following workout parameters: load (W) and heart rate (HR).19,20 The resistance exercise intensity was specified by the 1-RM (one repetition maximum) method. The maximum load lifted across the full range of motion for every exercise was used as the benchmark for the workload intensity specification, corresponding to 30 - 60% 1-RM.

Group 4

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers (without any disease, including the cardiovascular ones, and without any kind of treatment)
  • Patients with chronic ischemic coronary artery disease
  • Patients treated with ACE inhibitors, beta-blockers or statins.
  • To visit routinely in the health centres where the study is carried out

You may not qualify if:

  • Age under 18 years,
  • Pregnant, or breast-feeding,
  • Patients on dialysis or being followed by nephrology,
  • Severe physical or cognitive limitations,
  • Intolerance to the method of measurement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Anne´s University Hospital Brno

Brno, 654 91, Czechia

Location

MeSH Terms

Conditions

Cardiovascular DiseasesHypertensionMotor Activity

Condition Hierarchy (Ancestors)

Vascular DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Monocenter, non-randomized, controlled study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2022

First Posted

March 3, 2022

Study Start

June 20, 2018

Primary Completion

June 25, 2020

Study Completion

June 20, 2021

Last Updated

March 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations